FindTrial
Sign In

efficacy of 15(R/S)-methyl- lipoxin A4 (LXA4) inhalation in children with asthma

efficacy of 15(R/S)-methyl- lipoxin A4 inhalation in children with asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003279
Enrollment
Unknown
Registered
2013-06-14
Start date
2013-06-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

three groups:inhale LXA4

Sponsors

First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 14 Years

Inclusion criteria

Inclusion criteria: children(5-14y) with asthma

Exclusion criteria

Exclusion criteria: eczema,lower respiratory infection(within two weeks), diabetes mellitus, remal failure, CHD, epilepsy

Design outcomes

Primary

MeasureTime frame
pulmonary function test;—

Countries

China

Contacts

Public ContactWu Shenghua
kad-yc@163.com+86 13813848630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026